Informations générales (source: ClinicalTrials.gov)
Evaluation of the Performance of a 3D FGAPSIR Sequence by MRI in the Detection and Characterization of Spinal Cord Injuries in Patients With Multiple Sclerosis (ESPOIR2)
Observational
Fondation Ophtalmologique Adolphe de Rothschild (Voir sur ClinicalTrials)
octobre 2023
août 2024
29 juin 2024
- verification of inclusion and non-inclusion criteria
- information and collection of consent
- standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and
T2 slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR
sequence.
- 3D FGAPSIR sequence at the level of the cervical cord for the duration of the
additional sequence is 10 minutes, for a total examination time of 40 minutes
(instead of 30 minutes)
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL FONDATION A. DE ROTHSCHILD | Augustin LECLER | 21/06/2024 13:34:03 | Contacter | ||
Critères
Tous
Inclusion Criteria:
- Patient over 18 years old
- To benefit from a medullary exploration planned by 3T MRI as part of a first
evaluation or a reassessment of inflammatory involvement of the nevrax
- Express consent to participate in the study
- Affiliate or beneficiary of a social security scheme
- Patient over 18 years old
- To benefit from a medullary exploration planned by 3T MRI as part of a first
evaluation or a reassessment of inflammatory involvement of the nevrax
- Express consent to participate in the study
- Affiliate or beneficiary of a social security scheme
- Patient benefiting from a legal protection measure
- Pregnant, parturient or breastfeeding woman
- Absolute or relative contraindication to MRI